Home Nav
Nextech Invest Logo

Kai Wucherpfennig

Alfred Scheidegger

Kai Wucherpfennig MD PhD is Professor and Chair of the Department of Cancer Immunology and Virology at the Dana-Farber Cancer Institute and Professor of Neurology at Harvard Medical School.
Prof. Wucherpfennig’s research focuses on the discovery of genes that control the activity of cytotoxic T cells in the tumor microenvironment drawing insights for the development of next-generation cancer immunotherapies. He has received a number of honors and awards, including his election as a Fellow in the American Society for the Advancement of Science, his election as a member of the Henry Kunkel Society at Rockefeller University, and his election as a member of the American Society for Clinical Investigation. He received his MD and PhD degrees from the University of Goettingen and completed post-doctoral work in immunology at Brigham & Women’s Hospital, Harvard Medical School, and Harvard College. Wucherpfennig serves as an advisor to a number of immuno-oncology companies and since 2015 is an exclusive scientific consultant of Nextech Invest. 

 

AACR Annual Meeting 2017

01.04. – 05.04.2017

Washington, DC, USA

  • 28.03.2017

    Tracon Pharmaceuticals announces TRC694 data presentation...

  • 27.03.2017

    Blueprint Medicines to present on BLU-285 and BLU-554...

  • 22.03.2017

    Jounce Therapeutics to present at AACR annual meeting...

Close

Newsletter Registration

Please fill in the subscription form completely. If you wish to modify your personal data or to change/cancel your newsletter subscription, this is possible at any time.

A link to your subscription profile can be found in every newsletter email.

Preview

* Compulsory fields

Close

Newsletter Registration

Your eMail have been successfully registered.

Close